CASSH注册表:理由和研究设计
Mohamad Ezzeldin1, Ali Kerro2, Ameer E Hassan3
1Department of Neuroendovascular Surgery HCA Houston Healthcare Kingwood Kingwood TX.
Stroke (Hoboken, N.J.)
|January 26, 2026
概括
在综合性中风医院 (CASSH) 的动脉支架结果注册表评估了动脉支架 (CAS) 的结果. 这项研究强调了神经干预专业知识在中风中心的CAS程序中的重要性.
科学领域:
- 神经学 神经学
- 血管外科 血管外科
- 干预心脏病学 干预心脏病学
背景情况:
- 动脉疾病,特别是动脉硬化狭窄,是中风的主要原因.
- 动脉内关节切除术是传统的治疗方法,但动脉支架 (CAS) 是高风险患者的替代方案.
- 神经干预专家拥有对CAS至关重要的技能,但在研究中通常代表性不足.
研究的目的:
- 为了研究由神经干预专家进行的动脉支架 (CAS) 的结果.
- 为了解决神经干预专业知识在当前CAS研究中的不足.
- 为综合性中风中心提供关于CAS程序的全面见解.
主要方法:
- CASSH (综合性中风医院的动脉支架结果) 注册表是一项多中心,前性,观察性研究.
- 被纳入的是患有动脉狭窄症的患者,这些患者由神经干预医生接受CAS治疗.
- 数据收集包括基线,手术和术后临床和成像变量.
主要成果:
- 测量结果包括术后症状性中风 (出血/缺血),接入部位并发症,静脉栓塞和死亡率.
- 该注册表捕获详细的程序和患者数据进行全面分析.
- 结果将阐明CAS在现实环境中的并发症率和有效性.
结论:
- 当前的文献不充分地代表了神经干预学家在CAS中的作用和结果.
- 该CASSH注册表将增强对CAS管理和结果的理解.
- 在综合性中风中心强调神经干预专业知识是改善CAS结果的关键.
相关概念视频
Study Design in Statistics
10.0K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.0K
Study Designs in Epidemiology
948
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
948
Group Design
10.4K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.4K
Bioavailability Study Design: Single Versus Multiple Dose Studies
227
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
227
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
245
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
245
Bioavailability Study Design: Absolute Versus Relative Bioavailability
329
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
329


